CA
Centerpoint Advisors Portfolio holdings
AUM
$295M
1-Year Return
12.11%
This Quarter Return
-3.28%
1 Year Return
+12.11%
3 Year Return
+62.24%
5 Year Return
+110.08%
10 Year Return
–
AUM
$236M
AUM Growth
-$10.7M
(-4.4%)
Cap. Flow
-$1.9M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
60.79%
Holding
644
New
31
Increased
54
Reduced
112
Closed
32
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.52M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
$953K |
| 3 |
Teledyne Technologies
TDY
|
$346K |
| 4 |
Thermo Fisher Scientific
TMO
|
$88.6K |
| 5 |
Stryker
SYK
|
$68.3K |
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$1.52M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
$426K |
| 3 |
Apple
AAPL
|
$277K |
| 4 |
Eli Lilly
LLY
|
$243K |
| 5 |
iShares S&P 500 Value ETF
IVE
|
$194K |
Sector Composition
| 1 | Technology | 9.07% |
| 2 | Healthcare | 4.66% |
| 3 | Communication Services | 4.4% |
| 4 | Financials | 3.83% |
| 5 | Consumer Discretionary | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ecolab
ECL
$77.6B
| $34K | 0.01% |
200
| – | – |
|
177
Hexcel
HXL
$5.16B
| $33K | 0.01% |
500
| – | – |
|
178
Kimberly-Clark
KMB
$43.1B
| $33K | 0.01% |
275
+175
| +175% | +$21K |
|
179
Arm
ARM
$146B
| $32K | 0.01% |
+600
| New | +$32K |
|
180
Booking.com
BKNG
$178B
| $31K | 0.01% |
10
-10
| -50% | -$31K |
|
181
BP
BP
$87.4B
| $31K | 0.01% |
788
+250
| +46% | +$9.84K |
|
182
Cheesecake Factory
CAKE
$3.02B
| $31K | 0.01% |
1,012
| – | – |
|
183
Celanese
CE
$5.34B
| $31K | 0.01% |
245
| – | – |
|
184
GSK
GSK
$81.5B
| $31K | 0.01% |
846
| – | – |
|
185
KLA
KLAC
$119B
| $31K | 0.01% |
68
| – | – |
|
186
SPDR S&P 500 ETF Trust
SPY
$660B
| $30K | 0.01% |
70
-5
| -7% | -$2.14K |
|
187
A.O. Smith
AOS
$10.3B
| $29K | 0.01% |
435
| – | – |
|
188
Broadcom
AVGO
$1.58T
| $29K | 0.01% |
350
| – | – |
|
189
Baxter International
BAX
$12.5B
| $29K | 0.01% |
780
| – | – |
|
190
Quest Diagnostics
DGX
$20.5B
| $29K | 0.01% |
239
-2
| -0.8% | -$243 |
|
191
Goldman Sachs
GS
$223B
| $29K | 0.01% |
90
| – | – |
|
192
Hawkins
HWKN
$3.49B
| $29K | 0.01% |
+500
| New | +$29K |
|
193
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| $29K | 0.01% |
618
| – | – |
|
194
Moderna
MRNA
$9.78B
| $28K | 0.01% |
274
| – | – |
|
195
Novo Nordisk
NVO
$245B
| $28K | 0.01% |
+305
| New | +$28K |
|
196
Palantir
PLTR
$363B
| $28K | 0.01% |
1,730
| – | – |
|
197
Conagra Brands
CAG
$9.23B
| $27K | 0.01% |
1,000
| – | – |
|
198
GE HealthCare
GEHC
$34.6B
| $27K | 0.01% |
402
| – | – |
|
199
Halozyme
HALO
$8.76B
| $27K | 0.01% |
700
| – | – |
|
200
Northern Oil and Gas
NOG
$2.42B
| $27K | 0.01% |
676
-127
| -16% | -$5.07K |
|